Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition. / Kangas, Suvi T; Salpéteur, Cécile; Nikièma, Victor; Talley, Leisel; Briend, André; Ritz, Christian; Friis, Henrik; Kæstel, Pernille.

I: Clinical Nutrition, Bind 39, Nr. 11, 2020, s. 3512-3519.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kangas, ST, Salpéteur, C, Nikièma, V, Talley, L, Briend, A, Ritz, C, Friis, H & Kæstel, P 2020, 'Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition', Clinical Nutrition, bind 39, nr. 11, s. 3512-3519. https://doi.org/10.1016/j.clnu.2020.03.016

APA

Kangas, S. T., Salpéteur, C., Nikièma, V., Talley, L., Briend, A., Ritz, C., Friis, H., & Kæstel, P. (2020). Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition. Clinical Nutrition, 39(11), 3512-3519. https://doi.org/10.1016/j.clnu.2020.03.016

Vancouver

Kangas ST, Salpéteur C, Nikièma V, Talley L, Briend A, Ritz C o.a. Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition. Clinical Nutrition. 2020;39(11):3512-3519. https://doi.org/10.1016/j.clnu.2020.03.016

Author

Kangas, Suvi T ; Salpéteur, Cécile ; Nikièma, Victor ; Talley, Leisel ; Briend, André ; Ritz, Christian ; Friis, Henrik ; Kæstel, Pernille. / Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition. I: Clinical Nutrition. 2020 ; Bind 39, Nr. 11. s. 3512-3519.

Bibtex

@article{cb9eae2ea1ba40e687c5f79d05a5127f,
title = "Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition",
abstract = "Background & aims: Treatment of children with uncomplicated severe acute malnutrition (SAM) is based on ready-to-use therapeutic foods (RUTF) and aims for quick regain of lost body tissues while providing sufficient micronutrients to restore diminished body stores. Little evidence exists on the success of the treatment to establish normal micronutrient status. We aimed to assess the changes in vitamin A and iron status of children treated for SAM with RUTF, and explore the effect of a reduced RUTF dose.Methods: We collected blood samples from children 6-59 months old with SAM included in a randomised trial at admission to and discharge from treatment and analysed haemoglobin (Hb) and serum concentrations of retinol binding protein (RBP), ferritin (SF), soluble transferrin receptor (sTfR), C-reactive protein (CRP) and α1-acid glycoprotein (AGP). SF, sTfR and RBP were adjusted for inflammation (CRP and AGP) prior to analysis using internal regression coefficients. Vitamin A deficiency (VAD) was defined as RBP < 0.7 μmol/l, anaemia as Hb < 110 g/l, storage iron deficiency (sID) as SF < 12 μg/l, tissue iron deficiency (tID) as sTfR > 8.3 mg/l and iron deficiency anaemia (IDA) as both anaemia and sID. Linear and logistic mixed models were fitted including research team and study site as random effects and adjusting for sex, age and outcome at admission.Results: Children included in the study (n = 801) were on average 13 months of age at admission to treatment and the median treatment duration was 56 days [IQR: 35; 91] in both arms. Vitamin A and iron status markers did not differ between trial arms at admission or at discharge. Only Hb was 1.7 g/l lower (95% CI -0.3, 3.7; p = 0.088) in the reduced dose arm compared to the standard dose, at recovery. Mean concentrations of all biomarkers improved from admission to discharge: Hb increased by 12% or 11.6 g/l (95% CI 10.2, 13.0), RBP increased by 13% or 0.12 μmol/l (95% CI 0.09, 0.15), SF increased by 36% or 4.4 μg/l (95% CI 3.1, 5.7) and sTfR decreased by 16% or 1.5 mg/l (95% CI 1.0, 1.9). However, at discharge, micronutrient deficiencies were still common, as 9% had VAD, 55% had anaemia, 35% had sID, 41% had tID and 21% had IDA.Conclusion: Reduced dose of RUTF did not result in poorer vitamin A and iron status of children. Only haemoglobin seemed slightly lower at recovery among children treated with the reduced dose. While improvement was observed, the vitamin A and iron status remained sub-optimal among children treated successfully for SAM with RUTF. There is a need to reconsider RUTF fortification levels or test other potential strategies in order to fully restore the micronutrient status of children treated for SAM.",
keywords = "Faculty of Science, Vitamin A, Iron, Micronutrient, Severe acute malnutrition, Children, Ready-to-use therapeutic food",
author = "Kangas, {Suvi T} and C{\'e}cile Salp{\'e}teur and Victor Niki{\`e}ma and Leisel Talley and Andr{\'e} Briend and Christian Ritz and Henrik Friis and Pernille K{\ae}stel",
note = "Copyright {\textcopyright} 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.",
year = "2020",
doi = "10.1016/j.clnu.2020.03.016",
language = "English",
volume = "39",
pages = "3512--3519",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Elsevier",
number = "11",

}

RIS

TY - JOUR

T1 - Vitamin A and iron status of children before and after treatment of uncomplicated severe acute malnutrition

AU - Kangas, Suvi T

AU - Salpéteur, Cécile

AU - Nikièma, Victor

AU - Talley, Leisel

AU - Briend, André

AU - Ritz, Christian

AU - Friis, Henrik

AU - Kæstel, Pernille

N1 - Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

PY - 2020

Y1 - 2020

N2 - Background & aims: Treatment of children with uncomplicated severe acute malnutrition (SAM) is based on ready-to-use therapeutic foods (RUTF) and aims for quick regain of lost body tissues while providing sufficient micronutrients to restore diminished body stores. Little evidence exists on the success of the treatment to establish normal micronutrient status. We aimed to assess the changes in vitamin A and iron status of children treated for SAM with RUTF, and explore the effect of a reduced RUTF dose.Methods: We collected blood samples from children 6-59 months old with SAM included in a randomised trial at admission to and discharge from treatment and analysed haemoglobin (Hb) and serum concentrations of retinol binding protein (RBP), ferritin (SF), soluble transferrin receptor (sTfR), C-reactive protein (CRP) and α1-acid glycoprotein (AGP). SF, sTfR and RBP were adjusted for inflammation (CRP and AGP) prior to analysis using internal regression coefficients. Vitamin A deficiency (VAD) was defined as RBP < 0.7 μmol/l, anaemia as Hb < 110 g/l, storage iron deficiency (sID) as SF < 12 μg/l, tissue iron deficiency (tID) as sTfR > 8.3 mg/l and iron deficiency anaemia (IDA) as both anaemia and sID. Linear and logistic mixed models were fitted including research team and study site as random effects and adjusting for sex, age and outcome at admission.Results: Children included in the study (n = 801) were on average 13 months of age at admission to treatment and the median treatment duration was 56 days [IQR: 35; 91] in both arms. Vitamin A and iron status markers did not differ between trial arms at admission or at discharge. Only Hb was 1.7 g/l lower (95% CI -0.3, 3.7; p = 0.088) in the reduced dose arm compared to the standard dose, at recovery. Mean concentrations of all biomarkers improved from admission to discharge: Hb increased by 12% or 11.6 g/l (95% CI 10.2, 13.0), RBP increased by 13% or 0.12 μmol/l (95% CI 0.09, 0.15), SF increased by 36% or 4.4 μg/l (95% CI 3.1, 5.7) and sTfR decreased by 16% or 1.5 mg/l (95% CI 1.0, 1.9). However, at discharge, micronutrient deficiencies were still common, as 9% had VAD, 55% had anaemia, 35% had sID, 41% had tID and 21% had IDA.Conclusion: Reduced dose of RUTF did not result in poorer vitamin A and iron status of children. Only haemoglobin seemed slightly lower at recovery among children treated with the reduced dose. While improvement was observed, the vitamin A and iron status remained sub-optimal among children treated successfully for SAM with RUTF. There is a need to reconsider RUTF fortification levels or test other potential strategies in order to fully restore the micronutrient status of children treated for SAM.

AB - Background & aims: Treatment of children with uncomplicated severe acute malnutrition (SAM) is based on ready-to-use therapeutic foods (RUTF) and aims for quick regain of lost body tissues while providing sufficient micronutrients to restore diminished body stores. Little evidence exists on the success of the treatment to establish normal micronutrient status. We aimed to assess the changes in vitamin A and iron status of children treated for SAM with RUTF, and explore the effect of a reduced RUTF dose.Methods: We collected blood samples from children 6-59 months old with SAM included in a randomised trial at admission to and discharge from treatment and analysed haemoglobin (Hb) and serum concentrations of retinol binding protein (RBP), ferritin (SF), soluble transferrin receptor (sTfR), C-reactive protein (CRP) and α1-acid glycoprotein (AGP). SF, sTfR and RBP were adjusted for inflammation (CRP and AGP) prior to analysis using internal regression coefficients. Vitamin A deficiency (VAD) was defined as RBP < 0.7 μmol/l, anaemia as Hb < 110 g/l, storage iron deficiency (sID) as SF < 12 μg/l, tissue iron deficiency (tID) as sTfR > 8.3 mg/l and iron deficiency anaemia (IDA) as both anaemia and sID. Linear and logistic mixed models were fitted including research team and study site as random effects and adjusting for sex, age and outcome at admission.Results: Children included in the study (n = 801) were on average 13 months of age at admission to treatment and the median treatment duration was 56 days [IQR: 35; 91] in both arms. Vitamin A and iron status markers did not differ between trial arms at admission or at discharge. Only Hb was 1.7 g/l lower (95% CI -0.3, 3.7; p = 0.088) in the reduced dose arm compared to the standard dose, at recovery. Mean concentrations of all biomarkers improved from admission to discharge: Hb increased by 12% or 11.6 g/l (95% CI 10.2, 13.0), RBP increased by 13% or 0.12 μmol/l (95% CI 0.09, 0.15), SF increased by 36% or 4.4 μg/l (95% CI 3.1, 5.7) and sTfR decreased by 16% or 1.5 mg/l (95% CI 1.0, 1.9). However, at discharge, micronutrient deficiencies were still common, as 9% had VAD, 55% had anaemia, 35% had sID, 41% had tID and 21% had IDA.Conclusion: Reduced dose of RUTF did not result in poorer vitamin A and iron status of children. Only haemoglobin seemed slightly lower at recovery among children treated with the reduced dose. While improvement was observed, the vitamin A and iron status remained sub-optimal among children treated successfully for SAM with RUTF. There is a need to reconsider RUTF fortification levels or test other potential strategies in order to fully restore the micronutrient status of children treated for SAM.

KW - Faculty of Science

KW - Vitamin A

KW - Iron

KW - Micronutrient

KW - Severe acute malnutrition

KW - Children

KW - Ready-to-use therapeutic food

U2 - 10.1016/j.clnu.2020.03.016

DO - 10.1016/j.clnu.2020.03.016

M3 - Journal article

C2 - 32249112

VL - 39

SP - 3512

EP - 3519

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 11

ER -

ID: 240791520